By Canadian Press

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine

Sep 28, 2023 | 1:09 PM

OTTAWA — Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.  

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada. 

This is the second vaccine targeting XBB.1.5 that will be available in this country. 

Earlier this month, Health Canada authorized Moderna’s updated mRNA vaccine.

Both Pfizer and Moderna’s shots are one-dose vaccines for people five years of age and older.

Meaningful Mementos

Remembering Someone You've Lost at Christmas

Dec 03, 2024

Seasonal Sorrow

How Do You Get Through The Holidays When You're Grieving?

Nov 01, 2024

Upcoming Events at Oliver's

Grief & Loss and Estate Planning Seminars

Oct 02, 2024

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.  

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax. 

Novavax’s vaccine has been submitted for consideration in people 12 years of age and older. 

This report by The Canadian Press was first published Sept. 28, 2023.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press